These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Is the DDAVP-test helpful to diagnose children?]. Weissenbacher E, Acham-Roschitz B, Leschnik B, Muntean W. Hamostaseologie; 2010 Nov; 30 Suppl 1():S138-40. PubMed ID: 21042662 [Abstract] [Full Text] [Related]
43. Carriers and noncarriers of haemophilia A: I. Multivariate analysis of pedigree data, screening blood coagulation tests and factor VIII variables. Wahlberg T, Blombäck M, Brodin U. Thromb Res; 1982 Mar 01; 25(5):401-14. PubMed ID: 6803389 [Abstract] [Full Text] [Related]
44. DDAVP: does the drug have a direct effect on the vessel wall? Barnhart MI, Chen S, Lusher JM. Thromb Res; 1983 Jul 15; 31(2):239-53. PubMed ID: 6415852 [Abstract] [Full Text] [Related]
45. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 Jul 15; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
46. Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy. Xu L, Nichols TC, Sarkar R, McCorquodale S, Bellinger DA, Ponder KP. Proc Natl Acad Sci U S A; 2005 Apr 26; 102(17):6080-5. PubMed ID: 15837921 [Abstract] [Full Text] [Related]
47. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders. Brommer EJ, Barrett-Bergshoeff MM, Allen RA, Schicht I, Bertina RM, Schalekamp MA. Thromb Haemost; 1982 Oct 29; 48(2):156-61. PubMed ID: 6817444 [Abstract] [Full Text] [Related]
50. Concentrated DDAVP: further improvement in the management of mild factor VIII deficiencies. Ghirardini A, Mariani G, Iacopino G, Tirindelli MC, Solinas S, Moretti T. Thromb Haemost; 1987 Oct 28; 58(3):896-8. PubMed ID: 3124287 [Abstract] [Full Text] [Related]
51. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease. Gill JC, Ottum M, Schwartz B. J Pediatr; 2002 May 28; 140(5):595-9. PubMed ID: 12032528 [Abstract] [Full Text] [Related]
52. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP. Brommer EJ, Derkx FH, Barrett-Bergshoeff MM, Schalekamp MA. Thromb Haemost; 1984 Feb 28; 51(1):42-4. PubMed ID: 6426080 [Abstract] [Full Text] [Related]
55. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination]. Coelho E. Rev Hosp Clin Fac Med Sao Paulo; 1987 Feb 28; 42(6):273-6. PubMed ID: 3138751 [No Abstract] [Full Text] [Related]
57. [Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis]. Köhler M, Kotitschke R, Braun B, Hellstern P, Mörsdorf S, Pindur G, Heiden M, Wenzel E. Beitr Infusionsther; 1990 Feb 28; 26():136-41. PubMed ID: 1703813 [Abstract] [Full Text] [Related]